1 / 4
PT-141 (Bremelanotide) is a highly potent synthetic peptide analogue of α-MSH that may elicit aphrodisiac effects through stimulation of melanocortin receptors. PT-141 (Bremelanotide) consists of seven amino acids and is a cyclic, shortened lactam variant of alpha-Melanocyte-stimulating hormone (α-MSH), a multifunctional peptide that regulates a broad array of physiological functions.
In studies, bremelanotide was shown to induce lordosis in an animal model and was also effective in treating sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal disorder).
PT-141 has a peptide purity level exceeding 99.0% as determined by HPLC and MS.
Synthesized with no additives and supplied as a white lyophilized (freeze-dried) powder.
PT-141 is a synthetic peptide analogue consisting of seven amino acids. It is a cyclic, shortened lactam variant of alpha-Melanocyte-stimulating hormone (α-MSH).
PT-141 operates by stimulating central melanocortin receptors, which may elicit aphrodisiac and behavioral effects rather than acting directly on the vascular system.
In scientific evaluations, Bremelanotide was shown to induce lordosis in animal models and demonstrated efficacy in treating sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal disorder).
PT-141 exhibits a purity level exceeding 99.0%, verified through standard High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis.
This peptide is synthesized with zero additives and is packaged and supplied as a stable, white lyophilized (freeze-dried) powder.
